Observer bias in geometric morphometric (GM) landmark placement is a critical methodological challenge that can compromise data integrity and research reproducibility in biomedical and drug development research.
Morphometric classification, powered by machine learning, is revolutionizing quantitative analysis in biomedical research, from neuron-glia discrimination to brain tumor diagnostics.
The application of geometric morphometric (GM) classification rules to new, out-of-sample individuals is a critical challenge in biomedical research, particularly for clinical diagnostics and drug development.
Morphometric analysis is pivotal in biomedical research for discerning subtle phenotypic changes, yet its high-dimensional nature poses significant analytical challenges.
Allometric confounding, where size-related shape changes obscure other biological signals, presents a significant challenge in geometric morphometric taxonomy.
Geometric morphometrics (GM) is a powerful tool for quantifying biological shape in biomedical and clinical research.
Geometric morphometric (GM) analysis often faces the critical challenge of small sample sizes, which can compromise statistical power and classification reliability.
This article provides a comprehensive resource for researchers and professionals applying outline-based geometric morphometrics in identification tasks, such as in taxonomic classification or morphological phenotyping.
This article provides a comprehensive framework for understanding and correcting allometric effects in taxonomic geometric morphometric studies.
Geometric Morphometrics (GM) is a powerful multivariate tool for quantifying biological morphology, but its application in drug development and biomedical research is often constrained by small, incomplete, or imbalanced datasets.